Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 10, 2014, Pages E2084-E2092

  Figlioli, Gisella ^a   Köhler, Aleksandra ^b,k   Chen, Bowang ^b   Elisei, Rossella ^a   Romei, Cristina ^a   Cipollini, Monica ^a   Cristaudo, Alfonso ^a   Bambi, Franco ^c   Paolicchi, Elisa ^a   Hoffmann, Per ^d,e,f   Herms, Stefan ^d,e,f   Kalemba, Michal ^g   Kula, Dorota ^g   Pastor, Susana ^h,i   Marcos, Ricard ^h,i   Velázquez, Antonia ^h,i   Jarzab, Barbara ^g   Landi, Stefano ^a   Hemminki, Kari ^b,j   Försti, Asta ^b,j   Gemignani, Federica ^a   more..

^a UNIVERSITY OF PISA   (Italy)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF BONN   (Germany)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f UNIVERSITY OF BASEL   (Switzerland)

^g INSTITUTE OF ONCOLOGY   (Poland)

^h UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

ⁱ INSTITUTO DE SALUD CARLOS III   (Spain)

^j LUND UNIVERSITY   (Sweden)

^k St Agnes Hospital Bocholt gGmbH   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BATF GENE; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; CONTROLLED STUDY; DHX35 GENE; DIFFERENTIATED THYROID CANCER; EVIDENCE BASED MEDICINE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; ITALIAN (CITIZEN); MAJOR CLINICAL STUDY; POLISH CITIZEN; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; POPULATION RESEARCH; REPLICATION STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SPANIARD; ADENOCARCINOMA, FOLLICULAR; ADULT; CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; EPIDEMIOLOGY; FEMALE; GENE LOCUS; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; ITALY; MALE; PATHOLOGY; PREVALENCE; PROCEDURES; RISK FACTOR; THYROID NEOPLASMS;

ADENOCARCINOMA, FOLLICULAR; ADULT; CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INCIDENCE; ITALY; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; THYROID NEOPLASMS;

EID: 84907662220     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1734     Document Type: Article

References (35)

1. Sipos JA, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clin. Oncol (R Coll Radiol). 2010;22:395-404.
2. Morris LG, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg. 2010;200:454-461.
3. Yu GP, Li JC, Branovan D, McCormick S, Schantz SP. Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid. 2010;20:465-473.
4. Grande E, Diez JJ, Zafon C, Capdevila J. Thyroid cancer: molecular aspects and new therapeutic strategies. J Thyroid Res. 2012;2012:847108.
5. Dal Maso L, Bosetti C, La Vecchia C, Franceschi S. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control. 2009;20:75-86.
6. Fallah M, Pukkala E, Tryggvadottir L, et al. Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. J Med Genet. 2013;50:373-382.
7. Landa I, Robledo M. Association studies in thyroid cancer susceptibility: are we on the right track? J Mol Endocrinol. 2011;47:R43-R58.
8. Huo D, Olopade OI. Interpretation of genome-wide association study results. Oncology (Williston Park). 2010;24:643, 646.
9. Stadler ZK, Gallagher DJ, Thom P, Offit K. Genome-wide association studies of cancer: principles and potential utility. Oncology (Williston Park). 2010;24:629-637.
10. Gudmundsson J, Sulem P, Gudbjartsson DF, et al. Commonvariants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet. 2009;41:460-464.
11. Jones AM, Howarth KM, Martin L, et al. Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. J Med Genet. 2012;49:158-163.
12. Liyanarachchi S, Wojcicka A, Li W, et al. Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma. Thyroid. 2013;23:1532-1540.
13. Matsuse M, Takahashi M, Mitsutake N, et al. The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J Med Genet. 2011;48:645-648.
14. Takahashi M, Saenko VA, Rogounovitch TI, et al. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet. 2010;19:2516-2523.
15. Tomaz RA, Sousa I, Silva JG, et al. FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility. Clin Endocrinol (Oxf). 2012;77:926-933.
16. Wang YL, Feng SH, Guo SC, et al. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population. J Med Genet. 2013;50:689-695.
17. Gudmundsson J, Sulem P, Gudbjartsson DF, et al. Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet. 2012;44:319-322.
18. Köhler A, Chen B, Gemignani F, et al. Genome-wide association study on differentiated thyroid cancer. J Clin Endocrinol Metab. 2013;98:E1674-E1681.
19. Echlin DR, Tae HJ, Mitin N, Taparowsky EJ. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Oncogene. 2000;19:1752-1763.
20. Liao J, Humphrey SE, Poston S, Taparowsky EJ. Batf promotes growth arrest and terminal differentiation of mouse myeloid leukemia cells. Mol Cancer Res. 2011;9:350-363.
21. 3 is a mutant B-RAF-regulated inhibitor of G1-S progression in melanoma cells. Cancer Res. 2010;70:2891-2900.
22. 3 is a novel, epigenetically regulated tumor suppressor in gastric carcinogenesis. Gastroenterology. 2013;144:22-25.
23. van Roon EH, Boot A, Dihal AA, et al. BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer. Clin Epigenet. 2013;5:2.
24. 3 melanoblast developmental regulator gene in autosomal dominant vitiligo. J Invest Dermatol. 2005;125:388-391.
25. Alkhateeb A, Stetler GL, Old W, et al. Mapping of anautoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet. 2002;11:661-667.
26. Cordin O, Banroques J, Tanner NK, Linder P. The DEAD-box protein family of RNA helicases. Gene. 2006;367:17-37.
27. Yang L, Lin C, Liu ZR. Phosphorylations of DEAD box p68 RNA helicase are associated with cancer development and cell proliferation. Mol Cancer Res. 2005;3:355-363.
28. Abdelhaleem M. Do human RNA helicases have a role in cancer? Biochim Biophys Acta. 2004;1704:37-46.
29. Lee K, Pisarska MD, Ko JJ, et al. Transcriptional factor FOXL2 interacts with DP103 and induces apoptosis. Biochem Biophys Res Commun. 2005;336:876-881.
30. Zahnow CA. CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases. Expert Rev Mol Med. 2009;11:e12.
31. Jendrzejewski J, He H, Radomska HS, et al. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc Natl Acad Sci USA. 2012;109:8646-8651.
32. Novembre J, Johnson T, Bryc K, et al. Genes mirror geography within Europe. Nature. 2008;456:98-101.
33. Campa D, Rizzato C, Bauer AS, et al. Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. Cancer Epidemiol Biomarkers Prev. 2013;22:320-323.
34. Hutter CM, Young AM, Ochs-Balcom HM, Carty CL, et al. Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study. Cancer Epidemiol Biomarkers Prev. 2011;20:1950-1959.
35. Na R, Liu F, Zhang P, et al. Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men. Prostate. 2013;73:1623-1635.